New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Nutriband Inc.

Contributing Author

Recent Articles by Nutriband Inc.

Oct-10	Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch NTRB GlobeNewswire
Oct-08	Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology NTRB GlobeNewswire
Oct-08	Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference NTRB GlobeNewswire
Sep-24	Nutriband Inc. to Present at the MicroCap Rodeo Conference NTRB GlobeNewswire
Sep-10	Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl NTRB GlobeNewswire
Sep-03	Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000 NTRB GlobeNewswire
Aug-18	Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025 NTRB GlobeNewswire
Aug-11	Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election NTRB GlobeNewswire
Aug-08	FDA Grants Nutriband Meeting Request for Aversa Fentanyl Abuse Deterrent Fentanyl Patch NTRB GlobeNewswire
Jul-18	Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval NTRB GlobeNewswire
Jul-02	Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval NTRB GlobeNewswire
Jul-01	Nutriband Inc. added to the Russell Microcap Index, Russell Microcap Growth Index, Russell 3000E Index and Russell 3000E Growth Index NTRB GlobeNewswire
Jun-18	Nutriband and Kindeva Complete Commercial Manufacturing Process Scale-up for Aversa Fentanyl Abuse Deterrent Fentanyl Patch NTRB GlobeNewswire
Jun-09	Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology NTRB GlobeNewswire
Jun-03	Nutriband Inc. to present at the 2025 Noble Capital Markets Virtual Equity Conference NTRB GlobeNewswire
Jun-02	Nutriband Inc. Quarterly Report Highlights Record Revenue for Q1, 2025 up 63% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl NTRB GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.